Nplate 250 micrograms powder for solution for injection

DRUG3 trials

Sponsors

Fakultni Nemocnice Hradec Kralove, Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla, Centre Hospitalier Universitaire De Nantes

Conditions

Immune thrombocytopeniaPrimary immune thrombocytopeniathrombocytopenic patients undergoing cardiac surgery

Phase 2

Complex immunomodulatory therapy for patients with immune thrombocytopenia (T-MEM)

RecruitingCTIS2023-505788-35-00

Fakultni Nemocnice Hradec KraloveImmune thrombocytopenia

Start: 2025-06-11Target: 50Updated: 2025-05-29

Preoperative use of Romiplostim in thrombocytopenic patients undergoing cardiac surgery. A Phase 3, multicenter randomized double-blinded controlled against placebo study

Not yet recruitingCTIS2024-517710-15-00

Centre Hospitalier Universitaire De Nantesthrombocytopenic patients undergoing cardiac surgery

Target: 136Updated: 2025-12-15

Phase 3

A multicentre, randomized, open-label study of romiplostim plus dexamethasone vs dexamethasone in patients with newly diagnosed primary immune thrombocytopenia

Active, not recruitingCTIS2024-514147-28-00

Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De SevillaPrimary immune thrombocytopenia

Start: 2022-12-02Target: 86Updated: 2025-12-12